HCM vs XERS: stock comparison and AI forecast
Hutchmed (China) Ltd (HCM) and Xeris Biopharma Holdings, Inc. (XERS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HCM Hutchmed (China) Ltd
- Price
- $14.20 +6.7% · 6M
- Market Cap
- $2.53B
- P/E Ratio
- 25.4x
- Size
- mid-cap
- AI Forecast
XERS Xeris Biopharma Holdings, Inc.
- Price
- $13.08 +105.3% · 6M
- Market Cap
- $2.38B
- P/E Ratio
- 218.0x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- HCM and XERS have similar market capitalizations ($2.53B and $2.38B).
- HCM trades at 25.4 times trailing earnings, XERS at 218.0 times.
- Over the last six months XERS returned +105.3% and HCM +6.7%.
- XERS carries 7.68 times debt per unit of equity, against 0.41 times for HCM.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HCM | XERS |
|---|---|---|
| Market Cap | $2.53B | $2.38B |
| P/E Ratio | 25.36x | 218.00x |
| P/B Ratio | 2.04x | 48.88x |
| EPS | $0.56 | $0.06 |
| Book Value/Share | $6.96 | $0.27 |
| Revenue/Share | – | $2.02 |
Profitability & Margins
| Metric | HCM | XERS |
|---|---|---|
| ROIC | -5.8% | 16.2% |
| Gross Margin | – | 87.4% |
| Operating Margin | -7.0% | 12.7% |
| EBT Margin | 48.1% | 2.5% |
| Tax Rate | 12.5% | 0.0% |
Financial Health
| Metric | HCM | XERS |
|---|---|---|
| Current Ratio | 4.96x | 2.15x |
| Quick Ratio | 4.83x | 1.58x |
| D/E Ratio | 0.41x | 7.68x |
| Financial Leverage | 1.42x | 8.68x |
| Interest Coverage | -14.2x | 2.5x |
| Working Capital | $1.25B | $155M |
Cash Flow
| Metric | HCM | XERS |
|---|---|---|
| Operating Cash Flow | -$64M | $74M |
| OCF Growth YoY | – | 597.5% |
Operational Efficiency
| Metric | HCM | XERS |
|---|---|---|
| Asset Turnover | – | 0.87x |
| Receivables Turnover | – | 5.4x |
| Inventory Turnover | – | 0.6x |
| Fixed Assets Turnover | – | 79.4x |
| Days Sales Outstanding | – | 68 days |
| Days Inventory | – | 604 days |
| Payables Period | – | 63 days |
| Cash Conversion Cycle | – | 609 days |
Income Statement
| Metric | HCM | XERS |
|---|---|---|
| Total Revenue | – | $368M |
| Operating Income | -$83M | $47M |
| R&D Expense | $360M | $38M |
| SG&A Expense | $216M | $226M |
| Cost of Goods Sold | – | $46M |
Dividend & Shareholder Information
| Metric | HCM | XERS |
|---|---|---|
| Shares Outstanding | 178M | 182M |
HCM vs XERS: stock comparison and AI forecast
Which is bigger, HCM or XERS?
HCM and XERS have similar market capitalizations ($2.53B and $2.38B).
Which is cheaper on earnings, HCM or XERS?
HCM trades at 25.4 times trailing earnings, XERS at 218.0 times.
Which stock performed better over the last six months, HCM or XERS?
Over the last six months XERS returned +105.3% and HCM +6.7%.
Which one does Intratio's AI model rank higher, HCM or XERS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.